Skip to main content
SpringerLink
Log in

Viscosupplementation with Hyaluronans for Osteoarthritis of the Knee

Clinical Efficacy and Economic Implications

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Treatment with intra-articular viscosupplementation with hyaluronan (hyaluronic acid) and its derivatives is an important component of the management of osteoarthritis (OA) of the knee. Several intra-articular hyaluronan formulations are now available that vary in their physical properties, duration of effect and treatment schedules.

Although aspects regarding their mechanism of action are not completely understood, numerous clinical trials, systematic reviews and meta-analyses have confirmed the efficacy of intra-articular hyaluronan therapies for relieving OA-related pain and improving joint function. Data indicate that intra-articular hyaluronan preparations provide OA pain relief that is comparable to or greater than that observed with conventional treatment, NSAID medications, intra-articular corticosteroids, arthroscopic lavage, physical therapy and exercise. Other studies indicate that multiple courses of hyaluronan are effective.

Intra-articular hyaluronan formulations are well tolerated and are associated with a low incidence of adverse effects, usually localised to the injected joint. Local adverse events associated with intra-articular hyaluronan products are typically mild to moderate in severity, benign and transient, although their aetiology is unknown.

The cost effectiveness of intra-articular hyaluronan has been demonstrated, but only in a limited number of studies. Cost savings with intra-articular hyaluronan can also be realised with reduction of NSAID medication use and the possibility of delaying total knee replacement, which can reduce the need for costly revision procedures. Because different intra-articular hyaluronan formulations require different numbers of injections and office visits, are associated with variable treatment costs, and provide varying degrees of efficacy, not all intra-articular hyaluronan formulations may be equally cost effective over time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1

Similar content being viewed by others

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Centers for Disease Control and Prevention. Prevalence of disabilities and associated health conditions among adults: United States, 1999. MMWR 2001; 50: 120–5

    Google Scholar 

  2. Dillon CF, Rasch EK, Gu Q, et al. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health And Nutrition Examination Survey 1991–1994. J Rheumatol 2006; 33(11): 2271–9

    PubMed  Google Scholar 

  3. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000; 43: 1905–15

    Article  Google Scholar 

  4. Rodriguez-Monguio R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics 2003; 21: 623–50

    Article  PubMed  Google Scholar 

  5. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340: 1888–99

    Article  PubMed  CAS  Google Scholar 

  6. American Academy of Orthopaedic Surgeons. AAOS clinical guidelines and performance measures: knee osteoarthritis guideline (phase II) [online]. Available from URL: http://www.aaos.org/Research/guidelines/guide.asp [Accessed 2007 Jun 29]

  7. American Pain Society. Guidelines for the management of pain in osteoarthritis, rheumatoid arthritis, and juvenile chronic arthritis. 2nd ed. Glenview (IL): American Pain Society, 2002

    Google Scholar 

  8. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group [published erratum in J Rheumatol 1999; 26: 1216]. J Rheumatol 1998; 25: 2203–12

    PubMed  CAS  Google Scholar 

  9. Balazs EA, Watson D, Duff IF, et al. Hyaluronic acid in synovial fluid: I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967; 10: 357–76

    Article  PubMed  CAS  Google Scholar 

  10. Mazzucco D, Scott R, Spector M. Composition of joint fluid in patients undergoing total knee replacement and revision arthroplasty: correlation with flow properties. Biomaterials 2004; 25: 4433–45

    Article  PubMed  CAS  Google Scholar 

  11. Kaiyama J, Uzuki M. Alteration of hyaluronic acid property in synovial fluid of patients with osteoarthritis. J Iwate Med Assoc 2006; 58: 9–21

    CAS  Google Scholar 

  12. Smith MM, Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987; 7: 113–22

    Article  PubMed  Google Scholar 

  13. Bagga H, Burkhardt D, Sambrook P, et al. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006; 33: 946–50

    PubMed  CAS  Google Scholar 

  14. Synvisc® product information. Cambridge (MA): Genzyme Biosurgery, 2003

  15. Hyalgan® product information. Bridgewater (NJ): Sanofi-Synthelabo, 2001

  16. Supartz® product information. Tokyo: Seikagaku Corporation, 2001

  17. Orthovisc® product information. Woburn (MA): Anika Pharmaceuticals, 2004

  18. Euflexxa™ prescribing information. Suffern (NY): Ferring Pharmaceuticals, 2005

  19. Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee (review). Cochrane Database Syst Rev 2006; (2): CD005321

    Google Scholar 

  20. Drug topics redbook [CD-ROM]. Montvale (NJ): Medical Economics, 2006 Nov

  21. Rules and regulations. December 1, 2006. Federal Register 2006; 71(231): 69803, 70003

    Google Scholar 

  22. Neustadt D, Caldwell J, Bell M, et al. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Or-throvisc®) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol 2005; 32: 1928–36

    PubMed  CAS  Google Scholar 

  23. Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 2006; 14: 154–62

    Article  PubMed  CAS  Google Scholar 

  24. Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996; 23: 1579–85

    PubMed  CAS  Google Scholar 

  25. Wobig M, Beks P, Dickhut A, et al. Open-label multicenter trial of the safety and efficacy of viscosupplementation with hylan G-F 20 (Synvisc) in primary osteoarthritis of the knee. J Clin Rheumatol 1999; 5: S24–31

    Google Scholar 

  26. Evanich JD, Evanich CJ, Wright MB, et al. Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop Relat Res 2001; 390: 173–81

    Article  PubMed  Google Scholar 

  27. Waddell DD, Bricker D. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg 2006; 19: 19–27

    PubMed  Google Scholar 

  28. Carrabba MP, Paresce E, Angelini M, et al. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 1995; 15: 25–31

    Google Scholar 

  29. Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxf) 1999; 38: 602–7

    Article  CAS  Google Scholar 

  30. Jubb RW, Piva S, Beinat L, et al. A one-year, randomised, placebo (saline) controlled clinical trial of 500–730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 2003; 57: 467–74

    PubMed  CAS  Google Scholar 

  31. Lohmander LS, Dalen N, Englund G, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 1996; 55: 424–31

    Article  PubMed  CAS  Google Scholar 

  32. Day R, Brooks P, Conaghan PG, et al. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol 2004; 31: 775–82

    PubMed  CAS  Google Scholar 

  33. Brandt KD, Block JA, Michalski JP, et al. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis: ORTHOVISC Study Group. Clin Orthop Relat Res 2001; (385): 130–43

    Google Scholar 

  34. Grecomoro G, Martorana U, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 1987; 5: 137–41

    PubMed  CAS  Google Scholar 

  35. Wobig M, Dickhut A, Maier R, et al. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998; 20: 410–23

    Article  PubMed  CAS  Google Scholar 

  36. Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res 1994; 55: 220–32

    Article  Google Scholar 

  37. Henderson EB, Smith EC, Pegley F, et al. Intra-articular injections of 750 kDa hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis 1994; 53: 529–34

    Article  PubMed  CAS  Google Scholar 

  38. Karlsson J, Sjogren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis: a controlled, randomized, double-blind, parallel-design multicentre study. Rheumatol (Oxf) 2002; 41: 1240–8

    Article  CAS  Google Scholar 

  39. Tamir E, Robinson D, Koren R, et al. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol 2001; 19: 265–70

    Article  PubMed  CAS  Google Scholar 

  40. Lo GH, LaValley M, McAlindon T, et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2004; 290: 3115–21

    Article  Google Scholar 

  41. Wang CT, Lin J, Chang CJ, et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee: a meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004; 86–A: 538–45

    PubMed  Google Scholar 

  42. Arrich J, Piribauer F, Mad P, et al. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005; 172: 1039–43

    Article  PubMed  Google Scholar 

  43. Modawal A, Ferrer M, Choi HK, et al. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005; 54: 758–67

    PubMed  Google Scholar 

  44. Bjordal JM, Klovning A, Ljunggren AE, et al. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain 2006; 11(2): 125–38

    Article  PubMed  Google Scholar 

  45. Cohen MA, Shiroky JB, Ballachey ML, et al. Double-blind randomised trial of intra-articular (I/A) hyaluronate in the treatment of osteoarthritis of the knee [abstract]. Arthritis Rheum 1994; 37Suppl. 9: R31

    Google Scholar 

  46. Dixon AS, Jacoby RK, Berry H, et al. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 1988; 11: 205–13

    Article  PubMed  CAS  Google Scholar 

  47. Wu JJ, Shih LY, Hsu HC, et al. The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei) 1997; 59: 99–106

    CAS  Google Scholar 

  48. Corrado EM, Peluso GF, Gigliotti S, et al. The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm 1995; 15: 47–56

    Google Scholar 

  49. Creamer P, Sharif M, George E, et al. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage 1994; 2: 133–40

    Article  PubMed  CAS  Google Scholar 

  50. Dougados M, Nguyen M, Listrat V, et al. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo controlled trial. Osteoarthritis Cartilage 1993; 1: 97–103

    Article  PubMed  CAS  Google Scholar 

  51. Puhl W, Bernau A, Greiling H, et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter double-blind study. Osteoarthritis Cartilage 1993; 1: 233–41

    Article  PubMed  CAS  Google Scholar 

  52. Raynauld JP, Torrance G, Band P, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): clinical results. Osteoarthritis Cartilage 2002; 10: 506–17

    Article  PubMed  Google Scholar 

  53. Kahan A, Lleu PL, Salin L. Prospective randomized study comparing the medico-economic benefits of hylan G-F 20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine 2003; 70: 276–81

    Article  PubMed  Google Scholar 

  54. Dickson DJ, Hosie G, English JR. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 2001; 4: 41–52

    Google Scholar 

  55. Adams ME, Atkinson MH, Lussier AJ, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 1995; 3: 213–25

    Article  PubMed  CAS  Google Scholar 

  56. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2002; 162: 292–8

    Article  PubMed  CAS  Google Scholar 

  57. Caborn D, Rush J, Lanzer W, et al. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol 2004; 31: 333–43

    PubMed  CAS  Google Scholar 

  58. Frizziero L, Pasquali-Ronchetti I. Intra-articular treatment of osteoarthritis of the knee: an arthroscopic and clinical comparison between sodium hyaluronate (500–730 kDa) and methylprednisolone acetate. J Orthopaed Traumatol 2002; 3: 89–96

    Article  Google Scholar 

  59. Tascioglu F, Oner C. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol 2003; 22: 112–7

    Article  Google Scholar 

  60. Pietrogrande V, Melanotte PL, D’Agnolo B, et al. Hyaluronic acid versus methylprednisolone intra-articularly injected for treatment of osteoarthritis of the knee. Curr Ther Res 1991; 50: 691–701

    Google Scholar 

  61. Ozturk C, Atamaz F, Hepguler S, et al. The safety and efficacy of intraarticular hyaluronan with/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study. Rheum Int Clin Exper Investig 2005; 26: 314–9

    Google Scholar 

  62. Kotevoglu N, Iybozkurt PC, Hz O, et al. A prospective randomized controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int 2006; 26: 325–30

    Article  PubMed  CAS  Google Scholar 

  63. Karatosun V, Unver B, Gocen Z, et al. Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee: a prospective, randomized, double-blind study with long term follow-up. Clin Exp Rheumatol 2005; 23: 213–8

    PubMed  CAS  Google Scholar 

  64. Wobig M, Bach G, Beks P, et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 1999; 21: 1549–62

    Article  PubMed  CAS  Google Scholar 

  65. Pritchard CH, Sripada P, Bankes PF, et al. A retrospective comparison of the efficacy and tolerability of sodium hyaluronate and hylan G-F 20 in the treatment of osteoarthritis of the knee. J Musculoskel Res 2002; 6: 197–205

    Article  Google Scholar 

  66. Waddell DD, Cefalu CA, Bricker DC. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis. Curr Med Res Opin 2003; 19: 499–507

    Article  PubMed  CAS  Google Scholar 

  67. Waddell DD, Cefalu CA, Bricker DC. A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up. J Knee Surg 2005; 18: 7–15

    PubMed  Google Scholar 

  68. Raynauld JP, Goldsmith CH, Bellamy N, et al. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage 2005; 13: 111–9

    Article  PubMed  CAS  Google Scholar 

  69. Kotz R, Kolarz G. Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop 1999; 28: 5–7

    PubMed  CAS  Google Scholar 

  70. Kolarz G, Kotz R, Hochmayer I. Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 2003; 32: 310–9

    Article  PubMed  CAS  Google Scholar 

  71. Scali JJ. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a long term study. Eur J Rheumatol Inflamm 1995; 15: 57–62

    Google Scholar 

  72. Waddell DD. The tolerability of viscosupplementation: low incidence and clinical management of local adverse events. Curr Med Res Opin 2003; 19: Pl–6

    Google Scholar 

  73. Gray RG, Gottlieb NL. Intra-articular corticosteroids. An updated assessment. Clin Orthop Rel Res 1983; 177: 235–63

    Google Scholar 

  74. Zardawi IM, Chan I. Synvisc perisynovitis. Pathology 2001; 33: 519–20

    Article  PubMed  CAS  Google Scholar 

  75. Jackson DW, Evans NA, Thomas BM. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 2002; 84-A: 1522–7

    PubMed  Google Scholar 

  76. Schumacher Jr HR. Aspiration and injection therapies for joints. Arthritis Rheum 2003; 49: 413–20

    Article  PubMed  Google Scholar 

  77. Waddell DD, Bricker DC. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review. J Surg Orthop Adv 2006; 15: 53–9

    PubMed  Google Scholar 

  78. Gossec L, Dougados M. Do intra-articular therapies work and who will benefit most? Best Pract Res Clin Rheumatol 2006; 20: 131–44

    Article  PubMed  CAS  Google Scholar 

  79. Torrance GW, Raynauld JP, Walker V, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 2 of 2): economic results. Osteoarthritis Cartilage 2002; 10: 518–27

    Article  PubMed  CAS  Google Scholar 

  80. Yen ZS, Lai MS, Wang CT, et al. Cost-effectiveness of treatment strategies for osteoarthritis of the knee in Taiwan. J Rheumatol 2004; 31: 1797–803

    PubMed  Google Scholar 

  81. Kemper F, Gebhardt U, Meng T, et al. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 2005; 21: 1261–9

    Article  PubMed  CAS  Google Scholar 

  82. Waddell DD, Bricker D. Hylan G-F 20 reduces the probability of progression to total knee replacement in knee osteoarthritis [abstract]. Arthritis Rheum 2001; 44: S49

    Google Scholar 

  83. Forster MC, Straw R. A prospective randomised trial comparing intra-articular Hyalgan injection and arthroscopic washout for knee osteoarthritis. Knee 2003; 10: 291–3

    Article  PubMed  CAS  Google Scholar 

  84. Rahme E, Barkun AN, Adam V, et al. Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs. Drug Saf 2004; 27: 1019–42

    Article  PubMed  Google Scholar 

  85. Spiegel BM, Targownik L, Dulai GS, et al. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Ann Intern Med 2003; 138: 795–806

    PubMed  Google Scholar 

  86. Akarca US. Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs. Curr Pharm Des 2005; 11: 1779–93

    Article  PubMed  CAS  Google Scholar 

  87. Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2001 annual summary with detailed diagnosis and procedure data. Vital Health Stat 2004; 156: 1–198

    Google Scholar 

  88. The Institute of Orthopaedic Enlightenment. The ortho factbook: 2002–2003 series, US. 3rd ed. Chagrin Falls (OH): Knowledge Enterprises Inc., 2002

    Google Scholar 

  89. Burns AW, Bourne RB, Chesworth BM, et al. Cost effectiveness of revision total knee arthroplasty. Clin Orthop Relat Res 2006; 446: 29–33

    Article  PubMed  Google Scholar 

  90. Waddell D, Rein A, Panarites C, et al. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting. Am J Manag Care 2001; 7: 981–91

    PubMed  CAS  Google Scholar 

  91. Ong KL, Mowat FS, Chan N, et al. Economic burden of revision hip and knee arthroplasty in Medicare enrollees. Clin Orthop Relat Res 2006; 446: 22–8

    Article  PubMed  CAS  Google Scholar 

  92. Bourne RB, Maloney WJ, Wright JG. An AOA critical issue: the outcome of the outcomes movement. J Bone Joint Surg Am 2004; 86-A: 633–40

    PubMed  Google Scholar 

  93. Kurtz S, Mowat F, Ong K, et al. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 2005; 87: 1487–97

    Article  PubMed  Google Scholar 

  94. Bell M, Fallaha M, Lenczner E, et al. Viscosupplementation with hylan G-F 20 in total knee replacement candidates: an effective pain management therapy that may delay surgery [abstract]. Osteoarthritis Cartilage 1999; 7Suppl. A: S30

    Google Scholar 

  95. Marshall KW. Hylan G-F 20 (Synvisc®) salvage of patients failing a standardized arthroscopic debridement treatment algorithm. Poster presentation at the European Federation of National Association of Orthopedics Meeting; 1999 Jun 3–4; Brussels

  96. Waddell DD, Bricker DC. Total knee replacement delayed with hylan G-F 20 use in patients with grade IV osteoarthritis. J Manag Care Pharm 2007; 13: 113–21

    PubMed  Google Scholar 

Download references

Acknowledgements

The author acknowledges the financial support of Genzyme Biosurgery provided to medical writers, and the collaboration of medical writers Nicole Cooper and Kathleen Ohleth, PhD on manuscript development. Dr Waddell has received research grants from and is a consultant to Genzyme Biosurgery. Dr Waddell did not directly receive any financial support for preparation of the review.

Author information

Authors and Affiliations

  1. Orthopedic Specialists of Louisiana, 1500 Line Avenue, Shreveport, Louisiana, 71101, USA

    David D. Waddell

Authors
  1. David D. Waddell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David D. Waddell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waddell, D.D. Viscosupplementation with Hyaluronans for Osteoarthritis of the Knee. Drugs Aging 24, 629–642 (2007). https://doi.org/10.2165/00002512-200724080-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-200724080-00002

Keywords

Search

Navigation